ARCHIVES

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

This article is from The Cancer Letter archive.

Vol. 15 No. 09 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010

No Protective Effect From Long-Term Vitamin E or C

November 28, 2008

In Brief: Plastic Surgeon James French Named to NCAB; Clinton Re-Appoints Nienhuis

April 11, 2000

Lagging Government Salaries Spur NCI Turnover Among Senior Staff, Threaten Cancer Program

September 5, 1975

NCI Cooperative Group, Cancer Center Trials Listed

September 26, 2008

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014